JPY 1327.0
(1.3%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -1.86 Billion JPY | 12.86% |
2022 | -2.14 Billion JPY | -48.66% |
2021 | -1.44 Billion JPY | -15.79% |
2020 | -1.24 Billion JPY | 16.05% |
2019 | -1.48 Billion JPY | 12.15% |
2018 | -1.68 Billion JPY | -52.03% |
2017 | -1.11 Billion JPY | -23.92% |
2016 | -896.67 Million JPY | -6.48% |
2015 | -842.11 Million JPY | -20.55% |
2014 | -698.55 Million JPY | -65.65% |
2013 | -421.7 Million JPY | 4.1% |
2012 | -439.74 Million JPY | -70.96% |
2011 | -257.22 Million JPY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -2.08 Billion JPY | -11.78% |
2023 Q2 | -2.02 Billion JPY | -18.18% |
2023 Q3 | -1.17 Billion JPY | 42.07% |
2023 Q4 | -1.86 Billion JPY | -59.45% |
2023 FY | -1.86 Billion JPY | 12.86% |
2023 Q1 | -1.71 Billion JPY | 20.17% |
2022 Q1 | -1.31 Billion JPY | 9.17% |
2022 FY | -2.14 Billion JPY | -48.66% |
2022 Q4 | -2.14 Billion JPY | -60.54% |
2022 Q2 | -1.38 Billion JPY | -5.43% |
2022 Q3 | -1.33 Billion JPY | 3.29% |
2021 Q1 | -691.76 Million JPY | 44.48% |
2021 FY | -1.44 Billion JPY | -15.79% |
2021 Q2 | -1.06 Billion JPY | -53.39% |
2021 Q4 | -1.44 Billion JPY | -206.37% |
2021 Q3 | -470.87 Million JPY | 55.62% |
2020 Q1 | -1.37 Billion JPY | 7.46% |
2020 Q2 | -1.16 Billion JPY | 15.48% |
2020 FY | -1.24 Billion JPY | 16.05% |
2020 Q3 | -777.4 Million JPY | 33.03% |
2020 Q4 | -1.24 Billion JPY | -60.26% |
2019 Q1 | -1.37 Billion JPY | 18.83% |
2019 Q3 | -1.18 Billion JPY | 35.96% |
2019 FY | -1.48 Billion JPY | 12.15% |
2019 Q4 | -1.48 Billion JPY | -25.75% |
2019 Q2 | -1.84 Billion JPY | -34.39% |
2018 Q1 | -1.35 Billion JPY | -21.62% |
2018 FY | -1.68 Billion JPY | -52.03% |
2018 Q4 | -1.68 Billion JPY | -91.97% |
2018 Q3 | -880.01 Million JPY | 37.85% |
2018 Q2 | -1.41 Billion JPY | -4.78% |
2017 FY | -1.11 Billion JPY | -23.92% |
2017 Q1 | -434.31 Million JPY | 51.56% |
2017 Q4 | -1.11 Billion JPY | -4604.99% |
2017 Q2 | -676.73 Million JPY | -55.82% |
2017 Q3 | 24.66 Million JPY | 103.64% |
2016 Q2 | -760.37 Million JPY | 8.0% |
2016 Q4 | -896.67 Million JPY | -50.33% |
2016 FY | -896.67 Million JPY | -6.48% |
2016 Q1 | -826.52 Million JPY | 1.85% |
2016 Q3 | -596.48 Million JPY | 21.55% |
2015 Q4 | -842.11 Million JPY | -86.61% |
2015 Q2 | -642.84 Million JPY | -50.56% |
2015 Q3 | -451.26 Million JPY | 29.8% |
2015 Q1 | -426.97 Million JPY | 38.88% |
2015 FY | -842.11 Million JPY | -20.55% |
2014 Q2 | -553.82 Million JPY | -57.15% |
2014 FY | -698.55 Million JPY | -65.65% |
2014 Q1 | -352.41 Million JPY | 16.43% |
2014 Q3 | -515.58 Million JPY | 6.91% |
2014 Q4 | -698.55 Million JPY | -35.49% |
2013 Q4 | -421.7 Million JPY | -57.51% |
2013 Q3 | -267.73 Million JPY | 37.96% |
2013 Q2 | -431.53 Million JPY | -29.2% |
2013 Q1 | -334 Million JPY | 24.05% |
2013 FY | -421.7 Million JPY | 4.1% |
2012 Q2 | -444 Million JPY | 0.0% |
2012 Q4 | -439.74 Million JPY | -112.46% |
2012 Q3 | -206.97 Million JPY | 53.38% |
2012 FY | -439.74 Million JPY | -70.96% |
2011 FY | -257.22 Million JPY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Kitanotatsujin Corporation | -4.76 Billion JPY | 60.743% |
Euglena Co., Ltd. | 12.26 Billion JPY | 115.236% |
Axas Holdings Co.,Ltd. | 7.59 Billion JPY | 124.597% |
C.I. Medical Co.,Ltd. | 15.49 Billion JPY | 112.061% |
Kao Corporation | -30.59 Billion JPY | 93.891% |
Niitaka Co., Ltd. | -4.3 Billion JPY | 56.616% |
Rohto Pharmaceutical Co.,Ltd. | -73.75 Billion JPY | 97.466% |
Shiseido Company, Limited | 176.29 Billion JPY | 101.06% |
Lion Corporation | -55.18 Billion JPY | 96.613% |
Mandom Corporation | -26.87 Billion JPY | 93.047% |
Ivy Cosmetics Corporation | 242.95 Million JPY | 869.211% |
Milbon Co., Ltd. | -11.33 Billion JPY | 83.516% |
Nippon Shikizai, Inc. | 8.12 Billion JPY | 123.012% |
Fancl Corporation | -31.91 Billion JPY | 94.144% |
KOSÉ Corporation | -95.45 Billion JPY | 98.042% |
Cota Co., Ltd. | -3.69 Billion JPY | 49.417% |
HABA Laboratories,Inc. | -1.6 Billion JPY | -16.503% |
C'bon Cosmetics Co.,Ltd. | -3.62 Billion JPY | 48.508% |
Pola Orbis Holdings Inc. | -44.68 Billion JPY | 95.817% |
Noevir Holdings Co., Ltd. | -27.96 Billion JPY | 93.318% |
Adjuvant Holdings Co.,Ltd. | -2.08 Billion JPY | 10.493% |
Almado, Inc. | -511.88 Million JPY | -265.089% |
I-ne CO., LTD. | -8.92 Billion JPY | 79.07% |
Premier Anti-Aging Co., Ltd. | -2.31 Billion JPY | 19.377% |
Liberta Co.,Ltd. | 1.6 Billion JPY | 216.328% |
AXXZIA Inc. | -3.97 Billion JPY | 53.042% |
S.T. Corporation | -12.98 Billion JPY | 85.605% |
Kobayashi Pharmaceutical Co., Ltd. | -70.54 Billion JPY | 97.351% |
Earth Corporation | -7.5 Billion JPY | 75.099% |
Sagami Rubber Industries Co., Ltd. | 4.55 Billion JPY | 141.052% |
Asahi Eito Holdings Co.,Ltd. | 497.06 Million JPY | 475.977% |
Ya-Man Ltd. | -15.42 Billion JPY | 87.882% |
MTG Co., Ltd. | -16 Billion JPY | 88.323% |
TRANSACTION CO.,Ltd. | -5.05 Billion JPY | 62.998% |
SHOBIDO Corporation | -31.92 Million JPY | -5753.883% |
Artnature Inc. | -19.2 Billion JPY | 90.27% |
Pigeon Corporation | -32.53 Billion JPY | 94.256% |
Unicharm Corporation | -192.42 Billion JPY | 99.029% |
Paltac Corporation | -60.74 Billion JPY | 96.923% |
CB GROUP MANAGEMENT Co., Ltd. | 2.84 Billion JPY | 165.62% |